Monday, 26 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

TowardPi Raises RMB 300 Million in Series C Financing Round

January 27, 2025
CompanyDrug

Aosaikang Receives FDA Approval for ASKG915 Clinical Trial

January 27, 2025
CompanyDeals

Pfizer Exercises Option for Sisunatovir Rights with LianBio

January 27, 2025
CompanyDeals

Fosun Pharma Registers Comirnaty Vaccines in Hong Kong

January 27, 2025
CompanyDeals

XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments

January 27, 2025
Deals

Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services

January 27, 2025
CompanyDrug

CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment

January 27, 2025
CompanyDrug

Ascletis Pharma Receives USPTO Notice for ASC10 Patent

January 27, 2025
CompanyDrug

HutchMed Initiates Rolling NDA Submission for Elunate to US FDA

January 27, 2025
Legal / IPPolicy / Regulatory

PCAOB Report Signals Relief for US-Listed Chinese Biotechs

January 27, 2025
CompanyDeals

Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange

January 27, 2025
CompanyDrug

Simcere Pharmaceutical Completes Enrollment for SIM0417 COVID-19 Drug Trial

January 27, 2025
1 2 … 7 8 9 10 11 … 22 23
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up